01 1Suven Life Sciences Limited
01 1METYROSINE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-05-08
Pay. Date : 2020-03-19
DMF Number : 34329
Submission : 2020-02-04
Status : Active
Type : II
20
Suven Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is METYROSINE USP, with a corresponding US DMF Number 34329.
Remarkably, this DMF maintains an Active status since its submission on February 04, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 08, 2020, and payment made on March 19, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
